8 challenges defining pharma outsourcing in 2026

Preview text: challenges defining pharma outsourcing in 2026 96 49% of external manufacturing leaders…

Monday, May 4, 2026 at 5:00 PM EasternHubSpot

PharmaSource8 challenges defining pharma outsourcing in 2026

Image not available

No image available for this email.

Subject: 8 challenges defining pharma outsourcing in 2026
Preview text: challenges defining pharma outsourcing in 2026 96 49% of external manufacturing leaders…
From: news@pharmasource.global
Brand: PharmaSource
ESP: HubSpot
Sent: Mon May 4, 2026, 5:00 PM ET
Size: 72 KB
Images: 11
Links: 33, 3 of them buttons
Subject length: 48 characters

Against PharmaSource's usual

Sent in the 5 PM hour, which holds 17% of its emails; 33% arrive in the 2 AM hour. The subject is 48 characters; its average is 45.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

from news.pharmasource.global [172.246.37.169] by our receiving server with ESMTPS

Other sending headers (names only): X-Csa-Complaints, X-Mailin-Campaign, X-Mailin-Client, X-sib-id

	Oct 23, 2026 2:00 AM	6 themes from CDMO Live Americas 2026
	Oct 13, 2026 2:00 AM	The essential update on US external manufacturing
	May 14, 2026 5:00 AM	Makary resigns. Who's running the FDA now?
	May 4, 2026 5:00 PM	8 challenges defining pharma outsourcing in 2026 (this email)
	Apr 27, 2026 5:00 PM	AI, vibe coding and pharma manufacturing
	Apr 21, 2026 6:31 AM	Fill/finish capacity isn't the real constraint
	Apr 14, 2026 1:30 AM	Pharma's DTC shift is breaking the supply chain